MedPath

Hypothermia in Children After Trauma

Phase 3
Terminated
Conditions
Traumatic Brain Injury
Interventions
Procedure: induced moderate hypothermia
Registration Number
NCT00222742
Lead Sponsor
Phoenix Children's Hospital
Brief Summary

The primary hypothesis for this application for a multicenter phase III randomized clinical trial (RCT) is that induced moderate hypothermia (HYPO) (32-33 °C) after severe traumatic brain injury (TBI) in children and maintained for 48 hours will improve mortality at 3 months and 12 month functional outcome as assessed by the Glasgow Outcome Scale (GOS).

Detailed Description

The primary specific aim of this RCT is to determine the effect of induced moderate HYPO (32-33 °C) after severe TBI in children on mortality at 3 months post injury. The primary outcome measure will be the GOS; the primary time point for evaluation is 3 months. Further secondary functional outcome measures will include the GOS - Extended Pediatrics (GOS - E Peds), and Vineland Adaptive Behavior Scale (VABS) and will be assessed in conjunction with the GOS at 6 and 12 months post injury.

The secondary hypotheses are based on the results and analysis of the Pilot Clinical Trial (completed and recently published \[Adelson et al. NEUROSURGERY. 56 (4): 740-754, 2005\]). These secondary hypotheses include that induced moderate hypothermia (HYPO) (32-33 °C) after severe TBI in children and maintained for 48 h:

* will improve other outcome assessments including neurocognitive status on performance-based neuropsychological testing across the domains of intellectual development, learning and memory, language, motor and psychomotor skills, visuo-spatial abilities, attention and executive function, and behavior at only 6 and 12 months after injury;

* HYPO will improve long term outcome of all age ranges and across genders in infants, young, preadolescent, and adolescent children; AND

* HYPO will lessen intracranial hypertension and lessen the intensity of therapy necessary for control of ICP.

Based on these hypotheses, further secondary specific aims are proposed:

* Specific Aim 2: To determine the effect of early induced moderate HYPO (32-33°C) after severe TBI in children on global function and neurocognitive outcomes in the areas of intellectual ability/ development, memory and learning, and behavior at 6 and 12 months post injury.

* Specific Aim 3: To determine the effect of early induced moderate HYPO after severe TBI in children of different age ranges (\< 6 y and 6- \< 16 y) on mortality and 6 and 12 months functional and neurocognitive outcomes.

* Specific Aim 4: To determine the effect of early moderate HYPO after severe TBI in children on reducing intracranial hypertension and maintaining adequate cerebral perfusion pressure (CPP).

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
90
Inclusion Criteria
  1. Patients with a GCS </= 8
  2. Glasgow Motor Score < 6
  3. Closed head injury
  4. Age 0 < 18 y

Exclusion Criteria

  1. Unavailable to initiate cooling within 6 hours of injury
  2. Glasgow Coma Scale (GCS) score = 3 and abnormal brainstem function
  3. Normal initial CT scan (No blood, fracture, swelling, and/or shift)
  4. Penetrating brain injury
  5. No known mechanism of injury
  6. Unknown time of injury
  7. Uncorrectable coagulopathy (PT/PTT > 16/40 sec, INR > 1.7)
  8. Hypotensive episode (Systolic Blood Pressure <5th percentile for age>10 min)
  9. Documented Hypoxic episode (O2 saturation < 94% for > 30 min)
  10. Pregnancy
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Ainduced moderate hypothermiaInduced moderate hypothermia (32-33 C)
Primary Outcome Measures
NameTimeMethod
The primary specific aim of this RCT is to determine the effect of induced moderate HYPO (32-33 °C) after severe TBI in children on mortality.3 month post injury
Secondary Outcome Measures
NameTimeMethod
To determine the effect of HYPO after severe TBI in children on global function and neurocognitive outcomes in the areas of intellectual ability/development, memory and learning, and behavior.at 6 and 12 months post injury
To determine the effect of HYPO after severe TBI in children of different age ranges (< 6y; 6-<16y; and 16-<18y) on mortality and 6 and 12 months functional and neurocognitive outcomes.3, 6 and 12 months post injury
To determine the effect of HYPO after severe TBI in children on reducing intracranial hypertension and maintaining adequate cerebral perfusion pressure (CPP).7 days post injury

Trial Locations

Locations (30)

Nationwide Children's Hospital

🇺🇸

Columbus, Ohio, United States

Children's Hospital of Philadelphia

🇺🇸

Philadelphia, Pennsylvania, United States

University of Pittsburgh/Children's Hospital of Pittsburgh

🇺🇸

Pittsburgh, Pennsylvania, United States

University of Texas, Southwestern

🇺🇸

Dallas, Texas, United States

University of Miami

🇺🇸

Miami, Florida, United States

Princess Margaret Hospital for Children

🇦🇺

Subiaco, Perth, Western Australia, Australia

Phoenix Childrens Hospital

🇺🇸

Phoenix, Arizona, United States

Duke University

🇺🇸

Durham, North Carolina, United States

University of Washington

🇺🇸

Seattle, Washington, United States

Children's National Medical Center

🇺🇸

Washington, District of Columbia, United States

Royal Children's Hospital Melbourne

🇦🇺

Parkville, Victoria, Australia

British Columbia Children's Hospital

🇨🇦

Vancouver, British Columbia, Canada

Mayo Clinic in Rochester

🇺🇸

Rochester, Minnesota, United States

University of California, Davis Medical Center

🇺🇸

Sacramento, California, United States

Royal Children's Hospital, Brisbane

🇦🇺

Brisbane, Queensland, Australia

Mater Children's Hospital

🇦🇺

Brisbane, Queensland, Australia

Penn State Hershey Medical Center

🇺🇸

Hershey, Pennsylvania, United States

Washington University

🇺🇸

St. Louis, Missouri, United States

Carolinas Medical Center

🇺🇸

Charlotte, North Carolina, United States

Weill Cornell Medical Center

🇺🇸

New York, New York, United States

Cohen's Children's Hospital

🇺🇸

New Hyde Park, New York, United States

Cincinnati Children's Hospital Medical Center

🇺🇸

Cincinnati, Ohio, United States

Sydney Children's Hospital, Randwick

🇦🇺

Sydney, New South Wales, Australia

Children's Hospital at Westmead

🇦🇺

Westmead, New South Wales, Australia

Children's Youth and Women's Health Service

🇦🇺

North Adelaide, South Australia, Australia

Stollery Children's Hospital

🇨🇦

Edmonton, Alberta, Canada

University of Cape Town

🇿🇦

Rondebosch, Cape Town, South Africa

Starship Children's Hospital

🇳🇿

Auckland, New Zealand

Institute of Child Health, Univ. College London & Great Ormond

🇬🇧

Bloomsbury, London, United Kingdom

Birmingham Children's Hospital

🇬🇧

Birmingham, West Midlands, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath